Successful therapy of palmoplantar pustulosis with tofacitinib-Report on three cases
- 1 July 2020
- journal article
- letter
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 33 (4), e13753
- https://doi.org/10.1111/dth.13753
Abstract
Click on the article title to read more.This publication has 8 references indexed in Scilit:
- Phase Transformation Graph and Transformation Pathway Engineering for Shape Memory AlloysShape Memory and Superelasticity, 2020
- Successful treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis with tofacitinib: Report of caseJAAD Case Reports, 2020
- Tofacitinib for the treatment of recalcitrant palmoplantar pustulosis: A case reportAustralasian Journal of Dermatology, 2019
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritisJAAD Case Reports, 2019
- Interleukin‐17 receptor A blockade with brodalumab in palmoplantar pustular psoriasis: Report on four casesThe Journal of Dermatology, 2019
- Erratum: JAK inhibition as a therapeutic strategy for immune and inflammatory diseasesNature Reviews Drug Discovery, 2017
- Palmoplantar pustulosis – a cross-sectional analysis in GermanyDermatology Online Journal, 2017
- Successful treatment of palmoplantar pustulosis with rheumatoid arthritis, with tofacitinib: Impact of this JAK inhibitor on T-cell differentiationClinical Immunology, 2016